placeholder image
J. L. Walker All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: an NRG oncology/GOG study. 
    Gynecologic Oncology. 2025
  • Long-term follow-up and overall survival in NRG258, a randomized phase III trial of chemoradiation versus chemotherapy for locally advanced endometrial carcinoma. 
    Journal of Clinical Oncology. 2025
  • Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. 
    Gynecologic Oncology. 2022
  • Secondary surgical cytoreduction for recurrent ovarian cancer. 
    New England Journal of Medicine. 2019
    • Contact
    full name
  • J. L. Walker
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration